Ongoing research continues to evaluate long-term effects, optimal dosing, and safety profiles across diverse patient populations
This article explains the dosing framework from Phase 2 trial data, administration guidance, and key safety considerations
All state Medicaid programs cover at least one GLP-1 medication for Type 2 diabetes, and Ozempic is commonly included
The half-life for liraglutide is about 1014 h in humans (Agerso et al., 2005
Infections can affect blood glucose levels independently of medications, often causing hyperglycemia due to stress hormones and inflammatory responses
Activating both at full dose simultaneously, with no titration runway, is what community sources describe as the failure mode that drives discontinuation